Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | SNRNP70 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | SART3 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |